(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 2.66% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.17%.
Inspire Medical Systems's revenue in 2026 is $915,247,000.On average, 19 Wall Street analysts forecast INSP's revenue for 2026 to be $25,077,527,714, with the lowest INSP revenue forecast at $23,493,092,430, and the highest INSP revenue forecast at $29,619,921,284. On average, 19 Wall Street analysts forecast INSP's revenue for 2027 to be $26,301,222,321, with the lowest INSP revenue forecast at $23,521,329,320, and the highest INSP revenue forecast at $32,702,928,655.
In 2028, INSP is forecast to generate $28,806,814,106 in revenue, with the lowest revenue forecast at $25,159,068,937 and the highest revenue forecast at $37,831,669,889.